0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bioresorbable Ophthalmic Drug Delivery System Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-39G14325
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bioresorbable Ophthalmic Drug Delivery System Market Research Report 2023
BUY CHAPTERS

Global Bioresorbable Ophthalmic Drug Delivery System Market Research Report 2025

Code: QYRE-Auto-39G14325
Report
February 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bioresorbable Ophthalmic Drug Delivery System Market Size

The global market for Bioresorbable Ophthalmic Drug Delivery System was valued at US$ 344 million in the year 2024 and is projected to reach a revised size of US$ 535 million by 2031, growing at a CAGR of 6.6% during the forecast period.

Bioresorbable Ophthalmic Drug Delivery System Market

Bioresorbable Ophthalmic Drug Delivery System Market

Bioresorbable implants are inserted into the patient’s eye and safely absorbed by the body over time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bioresorbable Ophthalmic Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioresorbable Ophthalmic Drug Delivery System.
The Bioresorbable Ophthalmic Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bioresorbable Ophthalmic Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioresorbable Ophthalmic Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bioresorbable Ophthalmic Drug Delivery System Market Report

Report Metric Details
Report Name Bioresorbable Ophthalmic Drug Delivery System Market
Accounted market size in year US$ 344 million
Forecasted market size in 2031 US$ 535 million
CAGR 6.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Allergan, Re-Vana Therapeutics, PolyActiva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bioresorbable Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bioresorbable Ophthalmic Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Bioresorbable Ophthalmic Drug Delivery System Market growing?

Ans: The Bioresorbable Ophthalmic Drug Delivery System Market witnessing a CAGR of 6.6% during the forecast period 2025-2031.

What is the Bioresorbable Ophthalmic Drug Delivery System Market size in 2031?

Ans: The Bioresorbable Ophthalmic Drug Delivery System Market size in 2031 will be US$ 535 million.

Who are the main players in the Bioresorbable Ophthalmic Drug Delivery System Market report?

Ans: The main players in the Bioresorbable Ophthalmic Drug Delivery System Market are Boehringer Ingelheim, Allergan, Re-Vana Therapeutics, PolyActiva

What are the Application segmentation covered in the Bioresorbable Ophthalmic Drug Delivery System Market report?

Ans: The Applications covered in the Bioresorbable Ophthalmic Drug Delivery System Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Bioresorbable Ophthalmic Drug Delivery System Market report?

Ans: The Types covered in the Bioresorbable Ophthalmic Drug Delivery System Market report are Anterior Drug Delivery Methods, Posterior Drug Delivery Methods

Recommended Reports

Ophthalmic Drug Delivery

Drug Delivery Systems

Ophthalmic Implants & Treatments

1 Bioresorbable Ophthalmic Drug Delivery System Market Overview
1.1 Product Definition
1.2 Bioresorbable Ophthalmic Drug Delivery System by Type
1.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Anterior Drug Delivery Methods
1.2.3 Posterior Drug Delivery Methods
1.3 Bioresorbable Ophthalmic Drug Delivery System by Application
1.3.1 Global Bioresorbable Ophthalmic Drug Delivery System Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Bioresorbable Ophthalmic Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Bioresorbable Ophthalmic Drug Delivery System Revenue 2020-2031
1.4.2 Global Bioresorbable Ophthalmic Drug Delivery System Sales 2020-2031
1.4.3 Global Bioresorbable Ophthalmic Drug Delivery System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bioresorbable Ophthalmic Drug Delivery System Market Competition by Manufacturers
2.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bioresorbable Ophthalmic Drug Delivery System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bioresorbable Ophthalmic Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bioresorbable Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bioresorbable Ophthalmic Drug Delivery System, Product Type & Application
2.7 Global Key Manufacturers of Bioresorbable Ophthalmic Drug Delivery System, Date of Enter into This Industry
2.8 Global Bioresorbable Ophthalmic Drug Delivery System Market Competitive Situation and Trends
2.8.1 Global Bioresorbable Ophthalmic Drug Delivery System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bioresorbable Ophthalmic Drug Delivery System Players Market Share by Revenue
2.8.3 Global Bioresorbable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bioresorbable Ophthalmic Drug Delivery System Market Scenario by Region
3.1 Global Bioresorbable Ophthalmic Drug Delivery System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Region: 2020-2031
3.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Region: 2020-2025
3.2.2 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Region: 2026-2031
3.3 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region: 2020-2031
3.3.1 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region: 2020-2025
3.3.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region: 2026-2031
3.4 North America Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Bioresorbable Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.4.3 North America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Bioresorbable Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.5.3 Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2020-2031)
3.6.3 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Bioresorbable Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.7.3 Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2020-2031)
4.1.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2020-2025)
4.1.2 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2026-2031)
4.1.3 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Type (2020-2031)
4.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Type (2020-2031)
4.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Type (2020-2025)
4.2.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Type (2026-2031)
4.2.3 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Type (2020-2031)
4.3 Global Bioresorbable Ophthalmic Drug Delivery System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2020-2031)
5.1.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2020-2025)
5.1.2 Global Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2026-2031)
5.1.3 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Application (2020-2031)
5.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Application (2020-2031)
5.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Application (2020-2025)
5.2.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Application (2026-2031)
5.2.3 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Application (2020-2031)
5.3 Global Bioresorbable Ophthalmic Drug Delivery System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Company Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Allergan Bioresorbable Ophthalmic Drug Delivery System Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Re-Vana Therapeutics
6.3.1 Re-Vana Therapeutics Company Information
6.3.2 Re-Vana Therapeutics Description and Business Overview
6.3.3 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Product Portfolio
6.3.5 Re-Vana Therapeutics Recent Developments/Updates
6.4 PolyActiva
6.4.1 PolyActiva Company Information
6.4.2 PolyActiva Description and Business Overview
6.4.3 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Product Portfolio
6.4.5 PolyActiva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bioresorbable Ophthalmic Drug Delivery System Industry Chain Analysis
7.2 Bioresorbable Ophthalmic Drug Delivery System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bioresorbable Ophthalmic Drug Delivery System Production Mode & Process Analysis
7.4 Bioresorbable Ophthalmic Drug Delivery System Sales and Marketing
7.4.1 Bioresorbable Ophthalmic Drug Delivery System Sales Channels
7.4.2 Bioresorbable Ophthalmic Drug Delivery System Distributors
7.5 Bioresorbable Ophthalmic Drug Delivery System Customer Analysis
8 Bioresorbable Ophthalmic Drug Delivery System Market Dynamics
8.1 Bioresorbable Ophthalmic Drug Delivery System Industry Trends
8.2 Bioresorbable Ophthalmic Drug Delivery System Market Drivers
8.3 Bioresorbable Ophthalmic Drug Delivery System Market Challenges
8.4 Bioresorbable Ophthalmic Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Bioresorbable Ophthalmic Drug Delivery System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Bioresorbable Ophthalmic Drug Delivery System Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Bioresorbable Ophthalmic Drug Delivery System Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Bioresorbable Ophthalmic Drug Delivery System Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Bioresorbable Ophthalmic Drug Delivery System Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Bioresorbable Ophthalmic Drug Delivery System Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Bioresorbable Ophthalmic Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Bioresorbable Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Bioresorbable Ophthalmic Drug Delivery System, Product Type & Application
 Table 12. Global Key Manufacturers of Bioresorbable Ophthalmic Drug Delivery System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bioresorbable Ophthalmic Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioresorbable Ophthalmic Drug Delivery System as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bioresorbable Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2020-2025) & (K Units)
 Table 18. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Region (2020-2025)
 Table 19. Global Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2026-2031) & (K Units)
 Table 20. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Region (2026-2031)
 Table 21. Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Region (2020-2025)
 Table 23. Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Region (2026-2031)
 Table 25. North America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 27. North America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 28. North America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Bioresorbable Ophthalmic Drug Delivery System Sales (K Units) by Type (2020-2025)
 Table 51. Global Bioresorbable Ophthalmic Drug Delivery System Sales (K Units) by Type (2026-2031)
 Table 52. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Type (2020-2025)
 Table 53. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Type (2026-2031)
 Table 54. Global Bioresorbable Ophthalmic Drug Delivery System Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Bioresorbable Ophthalmic Drug Delivery System Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Type (2020-2025)
 Table 57. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Type (2026-2031)
 Table 58. Global Bioresorbable Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Bioresorbable Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Bioresorbable Ophthalmic Drug Delivery System Sales (K Units) by Application (2020-2025)
 Table 61. Global Bioresorbable Ophthalmic Drug Delivery System Sales (K Units) by Application (2026-2031)
 Table 62. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Application (2020-2025)
 Table 63. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Application (2026-2031)
 Table 64. Global Bioresorbable Ophthalmic Drug Delivery System Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Bioresorbable Ophthalmic Drug Delivery System Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Application (2020-2025)
 Table 67. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Application (2026-2031)
 Table 68. Global Bioresorbable Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Bioresorbable Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2026-2031)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Allergan Company Information
 Table 76. Allergan Description and Business Overview
 Table 77. Allergan Bioresorbable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Allergan Bioresorbable Ophthalmic Drug Delivery System Product
 Table 79. Allergan Recent Developments/Updates
 Table 80. Re-Vana Therapeutics Company Information
 Table 81. Re-Vana Therapeutics Description and Business Overview
 Table 82. Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Product
 Table 84. Re-Vana Therapeutics Recent Developments/Updates
 Table 85. PolyActiva Company Information
 Table 86. PolyActiva Description and Business Overview
 Table 87. PolyActiva Bioresorbable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. PolyActiva Bioresorbable Ophthalmic Drug Delivery System Product
 Table 89. PolyActiva Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Bioresorbable Ophthalmic Drug Delivery System Distributors List
 Table 93. Bioresorbable Ophthalmic Drug Delivery System Customers List
 Table 94. Bioresorbable Ophthalmic Drug Delivery System Market Trends
 Table 95. Bioresorbable Ophthalmic Drug Delivery System Market Drivers
 Table 96. Bioresorbable Ophthalmic Drug Delivery System Market Challenges
 Table 97. Bioresorbable Ophthalmic Drug Delivery System Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bioresorbable Ophthalmic Drug Delivery System
 Figure 2. Global Bioresorbable Ophthalmic Drug Delivery System Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bioresorbable Ophthalmic Drug Delivery System Market Share by Type: 2024 & 2031
 Figure 4. Anterior Drug Delivery Methods Product Picture
 Figure 5. Posterior Drug Delivery Methods Product Picture
 Figure 6. Global Bioresorbable Ophthalmic Drug Delivery System Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Bioresorbable Ophthalmic Drug Delivery System Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Bioresorbable Ophthalmic Drug Delivery System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Bioresorbable Ophthalmic Drug Delivery System Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Bioresorbable Ophthalmic Drug Delivery System Sales (2020-2031) & (K Units)
 Figure 14. Global Bioresorbable Ophthalmic Drug Delivery System Average Price (US$/Unit) & (2020-2031)
 Figure 15. Bioresorbable Ophthalmic Drug Delivery System Report Years Considered
 Figure 16. Bioresorbable Ophthalmic Drug Delivery System Sales Share by Manufacturers in 2024
 Figure 17. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Bioresorbable Ophthalmic Drug Delivery System Players: Market Share by Revenue in Bioresorbable Ophthalmic Drug Delivery System in 2024
 Figure 19. Bioresorbable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Bioresorbable Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 22. North America Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 23. United States Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 26. Europe Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Region (2020-2031)
 Figure 34. China Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Bioresorbable Ophthalmic Drug Delivery System by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Bioresorbable Ophthalmic Drug Delivery System by Type (2020-2031)
 Figure 53. Global Bioresorbable Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Bioresorbable Ophthalmic Drug Delivery System by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Bioresorbable Ophthalmic Drug Delivery System by Application (2020-2031)
 Figure 56. Global Bioresorbable Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2020-2031)
 Figure 57. Bioresorbable Ophthalmic Drug Delivery System Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS